Paper Explores Utility of Biomarker Testing in Early Diagnosis and Treatment of Synucleinopathies
Current biomarkers help early, specific identification of disease and advance continuing research into effective treatments New biomarker tests can enable early diagnosis and prompt treatment of symptoms associated with synucleinopathies, according to a new expert-led clinical proceedings paper from the Clinical Neurological Society of America. https://mma.prnewswire.com/media/2602930/Clinical_Neurological_Society_of_America_Logo.jpg Synuclienopathies are a collection of neurodegenerative disorders including Parkinson's […]